病毒感染The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.
期刊:Antimicrobial agents and chemotherapy发表年份:2009作者:Tsutomu Murakami; Sei Kumakura; Toru Yamazaki; Reiko Tanaka; Makiko Hamatake; Kazu Okuma; Wei Huang; Jonathan Toma; Jun Komano; Mikiro Yanaka; Yuetsu Tanaka; Naoki Yamamoto
